gastrointestinal stromal tumor
Conditions
Interventions
Preoperative imatinib treatment :None
Sponsors
Department of General Surgery, Zhongshan Hospital, Fudan University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: The inclusion criteria were (1) patients who were pathologically diagnosed with GIST by needle biopsy; (2) patients who were difficult to achieve R0 resection; (3) patients with massive tumors >10cm or tumors that required multi-visceral and extensive resection in whom intraoperative bleeding, rupture or iatrogenic dispersion were likely to occur; (4) patients whose tumors were located in special anatomical sites such as the gastroesophageal junction so that the function of the organ was easily damaged by surgery; and (5) patients at risk of postoperative recurrence, complications or mortality.
Exclusion criteria
Exclusion criteria: The exclusion criteria were (1) patients with recurrent and metastatic diseases; (2) patients with missing information; (3) non-surgical patients; and (4) patients with co-existing malignancies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relapse-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Date of last follow-up;Date of recurrence;Date of tumor metastasis;Gene mutation information;Mode of operation;Scope of operation;Tumor size;Mitotic counts;Age;Gender; | — |
Countries
China
Contacts
Public ContactHou Yingyong
Department of General Surgery, Zhongshan Hospital, Fudan University School of Medicine
Outcome results
None listed